4.7 Review

Emerging role of GCN5 in human diseases and its therapeutic potential

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Oncology

Persistent high glucose induced EPB41L4A-AS1 inhibits glucose uptake via GCN5 mediating crotonylation and acetylation of histones and non-histones

Weijie Liao et al.

Summary: Our study reveals that EPB41L4A-AS1/GCN5 complex inhibits glucose uptake by regulating histone and nonhistone acetylation or crotonylation, targeting GLUT4/2 and TXNIP. Inhibition of EPB41L4A-AS1 expression may be an effective strategy for the treatment of type 2 diabetes mellitus, as weaker glucose uptake ability is one of its major clinical features.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Oncology

Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis

Yufeng Dine et al.

Summary: The acetylation of K620 on the extracellular domain of LIFR is shown to be a promising biomarker for monitoring PCa progression, as it enhances the homodimerization of LIFR and activates various signaling pathways.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Cell Biology

GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway

Jia Li et al.

Summary: Pathological cardiac hypertrophy is a major risk factor for heart failure, characterized by abnormal remodeling of cardiomyocytes in response to pressure overload or other stress stimuli. The study reveals that GCN5 plays a significant role in promoting cardiac hypertrophy through excessive activation of the TAK1-JNK/p38 signaling pathway.

CELL DEATH & DISEASE (2022)

Review Genetics & Heredity

Posttranslational regulation of the GCN5 and PCAF acetyltransferases

Onyekachi E. Ononye et al.

Summary: This review summarizes the types and functions of posttranslational modifications that regulate Gcn5 in both yeast and human cells. Common themes, unanswered questions, and strategies for future research are also outlined.

PLOS GENETICS (2022)

Article Biochemistry & Molecular Biology

ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin

Bi Chen et al.

Summary: The study found that metformin reduces ATXN7L3B levels in HCC cells, decreases ATXN7L3B-induced tumor-initiating ability, and inhibits cancer stemness, supporting the anti-tumor activity and potential of metformin as an anticancer drug for HCC treatment.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Review Medicine, Research & Experimental

The GCN5: its biological functions and therapeutic potentials

Md. Ezazul Haque et al.

Summary: GCN5 is a highly studied histone acetyltransferase that plays essential roles in epigenetic regulation and chromatin modification. It is involved in diverse biological processes such as gene regulation, cellular proliferation, metabolism, and inflammation, and its dysregulation has been linked to various disorders. Understanding the role of GCN5 in disease progression and developing novel therapeutic agents targeting GCN5 are important areas of research.

CLINICAL SCIENCE (2021)

Article Cell Biology

GCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression

Gregory C. Addicks et al.

Summary: Protein lysine acetylation plays a crucial role in regulating muscle integrity by inhibiting the DNA binding of the transcription factor/repressor YY1. Through acetylation-dependent inhibition of YY1, GCN5 positively regulates muscle integrity by maintaining the expression of structural muscle proteins.

JOURNAL OF CELL BIOLOGY (2021)

Review Oncology

Towards precision medicine for AML

Hartmut Dohner et al.

Summary: The rapid advances in sequencing technologies have greatly improved our understanding of AML at the molecular level, leading to the development of precision medicine approaches. Challenges in this field include safely combining agents with different mechanisms of action, overcoming primary and secondary resistance, and designing future clinical trials to address these issues.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Cell Biology

Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis

Lifeng Feng et al.

Summary: p62, up-regulated in hepatocellular carcinoma, is associated with shorter overall survival in patients and promotes cell growth. Sirt1 deacetylates p62 at lysine 295 to disturb Keap1-mediated p62 poly-ubiquitination, thus promoting hepato-carcinogenesis. Targeting Sirt1 or p62 could be a reasonable strategy for the treatment of hepatocellular carcinoma.

CELL DEATH & DISEASE (2021)

Article Oncology

The impact of CBP expression in estrogen receptor-positive breast cancer

Wafaa S. Ramadan et al.

Summary: The study found that elevated expression of CBP and GCN5 in breast cancer patients and cell lines, especially in luminal A and B subtypes. Analysis of publicly available databases showed amplification of CREBBP and KAT2A genes in breast cancer patients. Patients with high CREBBP or KAT2A gene expression had better 5-year disease-free survival than the low gene expression group.

CLINICAL EPIGENETICS (2021)

Article Engineering, Biomedical

Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA

Ye Yuan et al.

Summary: A tumor-targeting, pH/redox dual-responsive nanosystem was designed for the co-delivery of chemo-drugs and siRNA. This nanosystem efficiently delivered DOX and siGCN5 into drug-resistant cancer cells, inhibiting tumor growth significantly and downregulating P-gp epigenetically. In an MDR breast tumor model, DOX and siGCN5 loaded HPMSNs effectively inhibited tumor growth, abolished P-gp expression, and minimized DOX's systemic toxicity.

ACTA BIOMATERIALIA (2021)

Article Microbiology

A unique GCN5 histone acetyltransferase complex controls erythrocyte invasion and virulence in the malaria parasite Plasmodium falciparum

Jun Miao et al.

Summary: The PfGCN5 complex in Plasmodium falciparum has a unique subunit composition and plays crucial roles in regulating global gene expression and parasite-specific pathways. Deletions of specific domains in PfGCN5 or PfPHD1 result in similar growth phenotypes, including reduced invasion rates and altered chromatin states, suggesting a targeted recruitment mechanism in regulating parasite-specific gene expression.

PLOS PATHOGENS (2021)

Review Oncology

Advancing targeted protein degradation for cancer therapy

Brandon Dale et al.

Summary: The development of small-molecule degraders such as proteolysis-targeting chimeras (PROTACs) has enabled the targeting of previously considered undruggable oncoproteins. This review discusses recent advances in the field, with a focus on opportunities and challenges for future development.

NATURE REVIEWS CANCER (2021)

Article Endocrinology & Metabolism

Combined overexpression of SIRT1 and knockout of GCN5 in adult skeletal muscle does not affect glucose homeostasis or exercise performance in mice

Kristoffer Svensson et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)

Article Multidisciplinary Sciences

Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma

Xin Wang et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Machine learning for target discovery in drug development

Tiago Rodrigues et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Crystal structure of GCN5 PCAF N-terminal domain reveals atypical ubiquitin ligase structure

Sachiko Toma-Fukai et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Review Chemistry, Medicinal

Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism

Mengyuan Huang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Loss of zebrafish Ataxin-7, a SAGA subunit responsible for SCA7 retinopathy, causes ocular coloboma and malformation of photoreceptors

Samantha Carrillo-Rosas et al.

HUMAN MOLECULAR GENETICS (2019)

Review Genetics & Heredity

The many lives of KATs - detectors, integrators and modulators of the cellular environment

Bilal N. Sheikh et al.

NATURE REVIEWS GENETICS (2019)

Review Cell Biology

Functions and mechanisms of non-histone protein acetylation

Takeo Narita et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Chemistry, Medicinal

Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening

Huan Xiong et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach

Zuni I. Bassi et al.

ACS CHEMICAL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Analysis of translation using polysome profiling

Heloise Chasse et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Chemistry, Medicinal

Designing novel inhibitors against histone acetyltransferase (HAT: GCN5) of Plasmodium falciparum

Amarjeet Kumar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Declining histone acetyltransferase GCN5 represses BMSC-mediated angiogenesis during osteoporosis

Huan Jing et al.

FASEB JOURNAL (2017)

Article Biochemistry & Molecular Biology

Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells

Evangelia A. Koutsogiannouli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors

Jayme L. Dahlin et al.

NATURE COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes

Kfir Sharabi et al.

Article Endocrinology & Metabolism

Histone Acetyltransferase GCN5 Regulates Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting NF-κB

Ping Zhang et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2016)

Article Biochemistry & Molecular Biology

Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expression

Sidra Majaz et al.

CELL AND BIOSCIENCE (2016)

Article Biochemistry & Molecular Biology

The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation

Leilei Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

Interferon regulatory factor 1 and histone H4 acetylation in systemic lupus erythematosus

Yiu Tak Leung et al.

EPIGENETICS (2015)

Article Biochemistry & Molecular Biology

GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways

Kun Liu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Biochemistry & Molecular Biology

Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors

Daniela Secci et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression

Yoonjin Lee et al.

NATURE (2014)

Article Biochemistry & Molecular Biology

The Deacetylase Sirt6 Activates the Acetyltransferase GCN5 and Suppresses Hepatic Gluconeogenesis

John E. Dominy et al.

MOLECULAR CELL (2012)

Article Biochemistry & Molecular Biology

And-1 is required for the stability of histone acetyltransferase Gcn5

Y. Li et al.

ONCOGENE (2012)

Review Cell Biology

Regulation of chromatin by histone modifications

Andrew J. Bannister et al.

CELL RESEARCH (2011)

Article Endocrinology & Metabolism

Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5

Paul W. Caton et al.

JOURNAL OF ENDOCRINOLOGY (2010)

Article Cell Biology

GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelA

Xicheng Mao et al.

GENES & DEVELOPMENT (2009)

Article Multidisciplinary Sciences

ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

Kathryn E. Wellen et al.

SCIENCE (2009)

Review Oncology

Biological determinants of endocrine resistance in breast cancer

Elizabeth A. Musgrove et al.

NATURE REVIEWS CANCER (2009)

Review Medicine, General & Internal

Molecular origins of cancer: Lung cancer

Roy S. Herbst et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Multidisciplinary Sciences

The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α

Agnes Coste et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Crystal structure of a binary complex between human GCN5 histone acetyltransferase domain and acetyl coenzyme A

Anja Schuetz et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)

Review Cardiac & Cardiovascular Systems

Ubiquitin and ubiquitin-like proteins in protein regulation

Joerg Herrmann et al.

CIRCULATION RESEARCH (2007)

Review Biochemistry & Molecular Biology

Chromatin modifications and their function

Tony Kouzarides

Review Cell Biology

Histone acetyltransferase complexes: one size doesn't fit all

Kenneth K. Lee et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Chemistry, Medicinal

Small-molecule inhibitors of histone acetyltransferase activity: Identification and biological properties

Antonello Mai et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60

JH Patel et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes

D Helmlinger et al.

HUMAN MOLECULAR GENETICS (2004)

Article Chemistry, Multidisciplinary

Design, synthesis, and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5

M Biel et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)

Article Biochemistry & Molecular Biology

Structural basis for histone and phosphohistone binding by the GCN5 histone acetyltransferase

A Clements et al.

MOLECULAR CELL (2003)

Article Biochemistry & Molecular Biology

Small molecule modulators of histone acetyltransferase p300

K Balasubramanyam et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Multidisciplinary Sciences

Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor

AN Poux et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Review Cell Biology

Histone acetyltransferases: function, structure, and catalysis

R Marmorstein et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)

Article Biochemistry & Molecular Biology

Kinetic mechanism of the histone acetyltransferase GCN5 from yeast

KG Tanner et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Review Microbiology

Acetylation of histones and transcription-related factors

DE Sterner et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)